Kaushik, Vidhu
Kaushik, Vidhu was paid $1.90M by Medicaid between Jan 2018 and Nov 2024, across 156 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 19% of everything it billed.
ROCHESTER, MN 55905
Next to other Clinical Pathology/Laboratory Medicine Physician providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,003 | $134K | |
| 2019 | 36,908 | $224K | |
| 2020 | 22,451 | $156K | |
| 2021 | 43,899 | $525K | |
| 2022 | 21,462 | $235K | |
| 2023 | 48,964 | $392K | |
| 2024incomplete | 42,306 | $234K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19% | 6,348 | 5,177 | $352K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.6% | 2,956 | 2,785 | $125K |
| 80053 | Comprehensive metabolic panel | 6.2% | 23,531 | 18,710 | $118K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6.2% | 483 | 468 | $117K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.6% | 30,777 | 22,011 | $87K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.4% | 3,936 | 3,771 | $83K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.4% | 3,933 | 3,770 | $83K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.4% | 1,444 | 1,353 | $65K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.5% | 6,129 | 5,775 | $48K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.5% | 1,991 | 1,713 | $47K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.9% | 7,162 | 6,685 | $35K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 905 | 809 | $35K |
144 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 1.7% | 7,594 | $32K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.6% | 425 | $31K |
| 87480 | 1.6% | 2,388 | $30K | |
| 87510 | 1.6% | 2,379 | $30K | |
| 83735 | 1.4% | 7,671 | $27K | |
| 82803 | 1.3% | 2,347 | $25K | |
| 88342 | 1.3% | 1,537 | $24K | |
| 87040 | 1.1% | 2,138 | $21K | |
| 87660 | 1.1% | 2,558 | $20K | |
| 82962 | 1.1% | 10,455 | $20K | |
| 83605 | 1.0% | 3,531 | $19K | |
| 87641 | <1% | 873 | $19K | |
| 87081 | <1% | 5,569 | $16K | |
| 84484 | <1% | 3,043 | $15K | |
| 82330 | <1% | 1,730 | $14K | |
| 80061 | Lipid panel | <1% | 4,108 | $14K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 982 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,716 | $13K |
| 87186 | <1% | 2,211 | $12K | |
| 85730 | <1% | 2,699 | $11K | |
| 83880 | <1% | 974 | $10K | |
| 88307 | <1% | 174 | $10K | |
| 85610 | <1% | 4,917 | $10K | |
| 86780 | <1% | 1,188 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,019 | $9K |
| 83690 | <1% | 2,747 | $9K | |
| 86850 | <1% | 2,780 | $8K | |
| 81025 | <1% | 3,684 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 307 | $8K |
| 80069 | <1% | 1,812 | $7K | |
| 84100 | <1% | 3,436 | $7K | |
| 81001 | <1% | 5,105 | $7K | |
| 82607 | <1% | 1,279 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 119 | $7K |
| 86901 | <1% | 2,979 | $7K | |
| 86140 | <1% | 2,756 | $6K | |
| 86803 | <1% | 804 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 304 | $6K |
| 84439 | <1% | 1,393 | $6K | |
| 84466 | <1% | 1,319 | $5K | |
| 82728 | <1% | 1,396 | $5K | |
| 86900 | <1% | 2,954 | $5K | |
| 87088 | <1% | 891 | $5K | |
| 80202 | <1% | 684 | $5K | |
| 85384 | <1% | 1,475 | $5K | |
| 82784 | <1% | 568 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 306 | $4K |
| 85379 | <1% | 1,047 | $4K | |
| 87340 | <1% | 610 | $4K | |
| 87070 | <1% | 1,240 | $4K | |
| 82570 | <1% | 1,553 | $4K | |
| 87147 | <1% | 2,167 | $4K | |
| 83540 | <1% | 1,210 | $4K | |
| 84702 | <1% | 809 | $4K | |
| 87581 | <1% | 174 | $4K | |
| 81003 | <1% | 3,209 | $3K | |
| 85027 | <1% | 1,200 | $3K | |
| 83970 | <1% | 223 | $3K | |
| 82746 | <1% | 566 | $3K | |
| 82805 | <1% | 143 | $3K | |
| 82550 | <1% | 976 | $3K | |
| 87486 | <1% | 120 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 122 | $3K |
| 86038 | <1% | 350 | $3K | |
| 83615 | <1% | 915 | $3K | |
| 85014 | <1% | 2,051 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 300 | $2K |
| 85652 | <1% | 1,555 | $2K | |
| 86003 | <1% | 74 | $2K | |
| 84703 | <1% | 536 | $2K | |
| 83516 | <1% | 320 | $2K | |
| 88341 | <1% | 40 | $2K | |
| 80047 | <1% | 372 | $2K | |
| 87205 | <1% | 820 | $2K | |
| 82043 | <1% | 818 | $2K | |
| 87075 | <1% | 206 | $1K | |
| 87493 | <1% | 59 | $1K | |
| 82565 | <1% | 607 | $1K | |
| 84550 | <1% | 612 | $1K | |
| 86920 | <1% | 287 | $1K | |
| 84478 | <1% | 516 | $1K | |
| 87077 | <1% | 392 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 131 | $1K |
| 86762 | <1% | 262 | $1K | |
| 86480 | <1% | 46 | $1K | |
| 85018 | <1% | 929 | $993.35 | |
| 88304 | <1% | 55 | $992.78 | |
| 80076 | <1% | 274 | $980.61 | |
| 87522 | Neg quan hep c or qual rna | <1% | 34 | $950.30 |
| 82248 | <1% | 441 | $933.32 | |
| 88141 | <1% | 167 | $852.32 | |
| 84145 | <1% | 47 | $849.38 | |
| 84295 | <1% | 467 | $831.96 | |
| 84156 | <1% | 722 | $812.05 | |
| 86706 | <1% | 111 | $756.70 | |
| 80074 | <1% | 37 | $711.88 | |
| 84132 | <1% | 478 | $682.24 | |
| 85045 | <1% | 554 | $661.31 | |
| 84481 | <1% | 131 | $652.51 | |
| 84146 | <1% | 100 | $644.99 | |
| 87505 | <1% | 12 | $634.44 | |
| 86235 | <1% | 13 | $601.80 | |
| 82785 | <1% | 118 | $530.49 | |
| 88112 | <1% | 20 | $440.72 | |
| 82247 | <1% | 166 | $413.42 | |
| 82947 | <1% | 358 | $408.35 | |
| 83655 | <1% | 75 | $403.31 | |
| 87899 | <1% | 36 | $336.00 | |
| 86360 | <1% | 24 | $324.42 | |
| 82140 | <1% | 65 | $279.41 | |
| 87045 | <1% | 40 | $246.00 | |
| 87427 | <1% | 39 | $243.75 | |
| 84480 | <1% | 52 | $235.61 | |
| 86665 | <1% | 12 | $230.40 | |
| 82670 | <1% | 25 | $209.50 | |
| 80306 | <1% | 30 | $179.30 | |
| 86308 | <1% | 66 | $153.60 | |
| 86359 | <1% | 12 | $135.84 | |
| 86696 | <1% | 13 | $131.30 | |
| 85347 | <1% | 51 | $129.78 | |
| 82951 | <1% | 19 | $119.70 | |
| 86645 | <1% | 13 | $118.56 | |
| 80177 | <1% | 28 | $113.06 | |
| 87184 | <1% | 25 | $112.50 | |
| 87210 | <1% | 30 | $111.63 | |
| 82533 | <1% | 14 | $100.65 | |
| 86695 | <1% | 13 | $99.45 | |
| 82950 | <1% | 47 | $99.08 | |
| 86880 | <1% | 26 | $98.60 | |
| 82272 | <1% | 94 | $95.55 | |
| 85049 | <1% | 84 | $86.18 | |
| 82274 | <1% | 17 | $85.00 | |
| 86200 | <1% | 14 | $73.25 | |
| 86225 | <1% | 12 | $70.80 | |
| 87807 | <1% | 15 | $65.39 | |
| 80164 | <1% | 14 | $62.02 | |
| 81015 | <1% | 53 | $61.57 | |
| 86431 | <1% | 17 | $61.54 | |
| 87046 | <1% | 40 | $50.40 | |
| 82009 | <1% | 33 | $43.97 | |
| 84300 | <1% | 17 | $36.04 | |
| 89051 | <1% | 12 | $33.60 | |
| 86592 | <1% | 13 | $24.00 | |
| 82945 | <1% | 12 | $18.48 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.